Apixaban use in end-stage kidney disease (ESKD) requires caution due to reduced renal clearance, which can lead to drug accumulation and heightened bleeding risk.
Dose adjustment is critical in ESKD to minimize bleeding risk.
Not recommended for venous thromboembolism treatment in ESKD without specialist input.
Close monitoring of hemoglobin, renal function, and bleeding symptoms is essential.
Consult nephrology or hematology for individualized assessment.
Apixaban is partially eliminated via the kidneys (about 27% renal excretion). In ESKD, impaired renal function leads to decreased clearance, resulting in higher plasma concentrations of the drug and its active metabolites, prolonging anticoagulant effects.
Increased risk of major bleeding events, such as gastrointestinal hemorrhage, intracranial bleeding, or systemic bleeding, particularly in patients on dialysis.
For non-valvular atrial fibrillation in ESKD patients on hemodialysis, a reduced dose of 5 mg twice daily may be considered if criteria for dose reduction are met (age ≥80, weight ≤60 kg, or serum creatinine ≥1.5 mg/dL); otherwise, 2.5 mg twice daily. Monitor for signs of bleeding, assess renal function regularly, and consider alternative anticoagulants like warfarin if risks outweigh benefits. Avoid in acute kidney injury without established dosing.
Was this helpful?
The content on SafeTo is for informational purposes only and does not constitute medical, veterinary, or professional advice. Always consult with a qualified professional for specific concerns.
Hot chocolate contains small amounts of tyramine and phenylethylamine, which can interact with MAOIs, potentially leading to a hypertensive crisis if consumed in large quantities, though the risk is generally low with moderate intake.
Kale, a vitamin K-rich leafy green, can interact with warfarin by potentially reducing its anticoagulant effects if intake is inconsistent or excessive.
Large amounts of lime juice may mildly interact with certain statins, similar to but less potent than grapefruit juice, by inhibiting drug metabolism and potentially increasing statin levels in the blood.
